Ajanta Pharma informs about disclosure

11 Mar 2025 Evaluate
Ajanta Pharma has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 10, 2025 for Aayush Agrawal (Trustee Aayush Agrawal Trust.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2671.85 -16.10 (-0.60%)
20-Jan-2026 12:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.80
Dr. Reddys Lab 1185.50
Cipla 1379.40
Zydus Lifesciences 876.55
Lupin 2165.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×